跳至主要内容
临床试验/JPRN-UMIN000008574
JPRN-UMIN000008574已完成未知

A prospective clinical study to evaluate the feasibility and safeness of the chemotherapy with weekly paclitaxel administration in cases with anaplastic thyroid cancer - ATCCJ-TXL-P2

Anaplastic Thyroid Carcinoma Consortium Japan0 个研究点目标入组 50 人开始时间: 2012年7月31日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patient who matches one of these criterion. (1) suspision for interstitial pneumonia or pulmonary fibrosis by chest radiograph (2) brain metastasis with symptom (3) presence of the active peptic ulcer (4) presence of the active other malignancies (5) fever more than 38C (6) severe complication (e.g. myocardial infarction within 3 months, heart failure with clinically problem, poorly controlled diabetes mellitus, severe infectious disease. (7) past history for severe drug allergy (8) past history of hypersisitivity to polyoxyethylated or hydrogenated castor oil (9) hypersisitivity to alcohol (10) pregnant or nursing women (11) difficult to entry due to psychological problem (12) previous chemotherapy or radiation therapy to the present illness (13) physician judged improper to entry this trial

研究者

发起方
Anaplastic Thyroid Carcinoma Consortium Japan

相似试验